PURE Bioscience, Inc. (PURE) Reports Q3 Loss of $0.05, Revenues Fall Year-Over-Year
PURE Bioscience, Inc. (NASDAQ: PURE) reported Q3 EPS of ($0.05), versus ($0.05) reported last year. Revenue for the quarter came in at $128.4 thousand, versus $536.5 thousand reported last year.